Evidence map›Paper›PMID 35666232›Full record

ArticleJournal of neuroendocrinology2022

Vasopressin acts as a synapse organizer in limbic regions by boosting PSD95 and GluA1 expression.

Limei Zhang, Teresa Padilla-Flores, Vito S Hernández, Mario A Zetter, Elba Campos-Lira, Laura I Escobar, Robert P Millar, Lee E Eiden

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Limei ZhangDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-7422-5136
Teresa Padilla-FloresDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Vito S HernándezDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-1486-1659
Mario A ZetterDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0001-7132-5345
Elba Campos-LiraDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Laura I EscobarDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0002-5142-8993
Robert P MillarDepartment of Physiology, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.ORCID 0000-0003-3606-2708
Lee E EidenSection on Molecular Neuroscience, NIMH-IRP, NIH, Bethesda, Maryland, USA.ORCID 0000-0001-7524-944X
Universidad Nacional Autónoma de México · MXUniversity of Cape Town · ZA

Funding

Chemical Coding Of NeurotransmissionZIAMH002386 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI EIDEN, LEE E. · 2009 to 2025
$25.6M
Intramural NIH HHS ZIA MH002386NIMH NIH HHS ZIAMH0002386
6 · The paper itself

Abstract

Hypothalamic arginine vasopressin (AVP)-containing magnocellular neurosecretory neurons (AVPMNN) emit collaterals to synaptically innervate limbic regions influencing learning, motivational behaviour, and fear responses. Here, we characterize the dynamics of expression changes of two key determinants for synaptic strength, the postsynaptic density (PSD) proteins AMPAR subunit GluA1 and PSD scaffolding protein 95 (PSD95), in response to in vivo manipulations of AVPMNN neuronal activation state, or exposure to exogenous AVP ex vivo. Both long-term water deprivation in vivo, which powerfully upregulates AVPMNN metabolic activity, and exogenous AVP application ex vivo, in brain slices, significantly increased GluA1 and PSD95 expression as measured by western blotting, in brain regions reportedly receiving direct ascending innervations from AVPMNN (i.e., ventral hippocampus, amygdala and lateral habenula). By contrast, the visual cortex, a region not observed to receive AVPMNN projections, showed no such changes. Ex vivo application of V1a and V1b antagonists to ventral hippocampal slices ablated the AVP stimulated increase in postsynaptic protein expression measured by western blotting. Using a modified expansion microscopy technique, we were able to quantitatively assess the significant augmentation of PSD95 and GLUA1 densities in subcellular compartments in locus coeruleus tyrosine hydroxylase immunopositive fibres, adjacent to AVP axon terminals. Our data strongly suggest that the AVPMNN ascending system plays a role in the regulation of the excitability of targeted neuronal circuits through upregulation of key postsynaptic density proteins corresponding to excitatory synapses.

Indexed as

SynapsesTyrosine 3-MonooxygenaseArginine VasopressinHippocampusHypothalamusArginine VasopressinTyrosine 3-Monooxygenasecentral amygdalaexpansion microscopyventral hippocampuswater deprivationwestern blotting

Identifiers

PMID35666232
PMCPMC9787762
OpenAlexW4280560525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.